The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

New molecule BX795 clears latent HSV-1 from cultured infected cells

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by Wonkmonk, Apr 16, 2018 at 5:40 PM.

  1. Wonkmonk

    Wonkmonk Senior Member

    Messages:
    555
    Likes:
    726
    Germany
    "[A] small drug molecule called BX795, which is sold to labs for use in experiments, helped clear HSV-1 infection in cultured human corneal cells, in donated human corneas, and in the corneas of mice infected with HSV-1. [...] Additionally, the concentration of BX795 needed to clear HSV-1 infection is quite low. We saw clearance of the virus at concentrations of BX795 that were five times lower than concentrations of antiviral compounds in available nucleoside analogs, Shukla said. [...] Because BX795 targets a common pathway that many viruses use to replicate inside the cell, it could be a new kind of broad-spectrum antiviral that might be used to treat other viral infections. [...] Because of BX795's low toxicity, it has a great potential for systemic use as well as topical application."

    https://www.sciencedaily.com/releases/2018/02/180215110339.htm
     
    Sancar, Hip, junkcrap50 and 4 others like this.
  2. BadBadBear

    BadBadBear Senior Member

    Messages:
    419
    Likes:
    552
    Rocky Mountains
    Wow! That would be an amazing advancement, esp. if its truly not very toxic. Good article, @Wonkmonk
     
    Wonkmonk likes this.
  3. nanonug

    nanonug Senior Member

    Messages:
    1,574
    Likes:
    878
    Virginia, USA
    That is great news if usable by humans!
     
  4. Hip

    Hip Senior Member

    Messages:
    10,348
    Likes:
    16,759
    BX795 is also a PDK1 inhibitor, which might be useful in ME/CFS given, that Fluge and Mella found significant upregulation of PDK1, PDK2, and PDK4 in PBMCs from ME/CFS patients.
     
    Last edited: Apr 16, 2018 at 8:05 PM
  5. nanonug

    nanonug Senior Member

    Messages:
    1,574
    Likes:
    878
    Virginia, USA
    I believe it's a "different" PDK1, namely, phosphoinositide-dependent kinase-1.
     
    Hip likes this.
  6. Hip

    Hip Senior Member

    Messages:
    10,348
    Likes:
    16,759
    Ah right, well spotted. I'll strike out my above comment to prevent any misunderstanding.
     
    Wonkmonk and BadBadBear like this.
  7. Wonkmonk

    Wonkmonk Senior Member

    Messages:
    555
    Likes:
    726
    Germany

See more popular forum discussions.

Share This Page